These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 2497975

  • 1. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ, Sartorelli AC.
    Cancer Res; 1989 Jun 15; 49(12):3302-9. PubMed ID: 2497975
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC, Quax PH, Löwik CW, Verheijen JH.
    J Bone Miner Res; 1995 Sep 15; 10(9):1374-84. PubMed ID: 7502710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ.
    Cancer Res; 1998 Nov 15; 58(22):5221-30. PubMed ID: 9823336
    [Abstract] [Full Text] [Related]

  • 12. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr 15; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 13. Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells.
    Borchers AH, Sanders LA, Powell MB, Bowden GT.
    Exp Cell Res; 1997 Feb 25; 231(1):61-5. PubMed ID: 9056412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G, Bjornsson TD, Vlodavsky I.
    J Cell Physiol; 1993 Mar 25; 154(3):456-65. PubMed ID: 8436596
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
    Baker MS, Bleakley P, Woodrow GC, Doe WF.
    Cancer Res; 1990 Aug 01; 50(15):4676-84. PubMed ID: 2114945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.